These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34216835)

  • 21. Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?
    Lv Q; Zhou F; Liu X; Zhi L
    Bioorg Chem; 2023 Dec; 141():106894. PubMed ID: 37776682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behind the scenes: A medical natural language processing project.
    Wu JT; Dernoncourt F; Gehrmann S; Tyler PD; Moseley ET; Carlson ET; Grant DW; Li Y; Welt J; Celi LA
    Int J Med Inform; 2018 Apr; 112():68-73. PubMed ID: 29500024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential applications of artificial intelligence in drug discovery and development.
    Farghali H; Kutinová Canová N; Arora M
    Physiol Res; 2021 Dec; 70(Suppl4):S715-S722. PubMed ID: 35199553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2.
    Alsharif MH; Alsharif YH; Albreem MA; Jahid A; Solyman AAA; Yahya K; Alomari OA; Hossain MS
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11977-11981. PubMed ID: 33275275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19.
    Ahmed F; Soomro AM; Chethikkattuveli Salih AR; Samantasinghar A; Asif A; Kang IS; Choi KH
    Biomed Pharmacother; 2022 Sep; 153():113350. PubMed ID: 35777222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep learning-based natural language processing in ophthalmology: applications, challenges and future directions.
    Yang LWY; Ng WY; Foo LL; Liu Y; Yan M; Lei X; Zhang X; Ting DSW
    Curr Opin Ophthalmol; 2021 Sep; 32(5):397-405. PubMed ID: 34324453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting COVID-19 in China Using Hybrid AI Model.
    Zheng N; Du S; Wang J; Zhang H; Cui W; Kang Z; Yang T; Lou B; Chi Y; Long H; Ma M; Yuan Q; Zhang S; Zhang D; Ye F; Xin J
    IEEE Trans Cybern; 2020 Jul; 50(7):2891-2904. PubMed ID: 32396126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial Intelligence and the Future of the Drug Safety Professional.
    Danysz K; Cicirello S; Mingle E; Assuncao B; Tetarenko N; Mockute R; Abatemarco D; Widdowson M; Desai S
    Drug Saf; 2019 Apr; 42(4):491-497. PubMed ID: 30343417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comprehensive Study of Artificial Intelligence and Machine Learning Approaches in Confronting the Coronavirus (COVID-19) Pandemic.
    Rahman MM; Khatun F; Uzzaman A; Sami SI; Bhuiyan MA; Kiong TS
    Int J Health Serv; 2021 Oct; 51(4):446-461. PubMed ID: 33999732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19: Discovery, diagnostics and drug development.
    Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
    J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fighting COVID-19 with Artificial Intelligence.
    Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
    Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revolution of echocardiographic reporting: the new era of artificial intelligence and natural language processing.
    Kusunose K
    J Echocardiogr; 2023 Sep; 21(3):99-104. PubMed ID: 37312003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability.
    Debnath SK; Debnath M; Srivastava R; Omri A
    Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1187-1204. PubMed ID: 35615888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources.
    Liang L; Hu J; Sun G; Hong N; Wu G; He Y; Li Y; Hao T; Liu L; Gong M
    Drug Saf; 2022 May; 45(5):511-519. PubMed ID: 35579814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction.
    Lin X; Dai L; Zhou Y; Yu ZG; Zhang W; Shi JY; Cao DS; Zeng L; Chen H; Song B; Yu PS; Zeng X
    Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37401373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Big Data and Artificial Intelligence in COVID-19 Prevention, Diagnosis, Treatment and Management Decisions in China.
    Dong J; Wu H; Zhou D; Li K; Zhang Y; Ji H; Tong Z; Lou S; Liu Z
    J Med Syst; 2021 Jul; 45(9):84. PubMed ID: 34302549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus.
    Senthilraja M
    SLAS Technol; 2021 Apr; 26(2):123-126. PubMed ID: 33390088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Millennia-Long Development of Drugs Associated with the 80-Year-Old Artificial Intelligence Story: The Therapeutic Big Bang?
    Crouzet A; Lopez N; Riss Yaw B; Lepelletier Y; Demange L
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing preclinical drug discovery with artificial intelligence.
    Vijayan RSK; Kihlberg J; Cross JB; Poongavanam V
    Drug Discov Today; 2022 Apr; 27(4):967-984. PubMed ID: 34838731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ChatGPT in Drug Discovery: A Case Study on Anticocaine Addiction Drug Development with Chatbots.
    Wang R; Feng H; Wei GW
    J Chem Inf Model; 2023 Nov; 63(22):7189-7209. PubMed ID: 37956228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.